HIV Surveillance by Ali Mirzazadeh & Saharnaz Nedjat
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Ali Mirzazadeh1,2 and Saharnaz Nedjat3 
1Regional Knowledge Hub for HIV/AIDS Surveillance, 
Kerman University of Medical Sciences, Kerman, 
2HIV/AIDS & Communicable Disease Unit, 
WHO Representative Office, Tehran, 
3School of Public Health, Knowledge Utilization Research Center, 
Tehran University of Medical Science, 
Iran 
1. Introduction 
Epidemiological surveillance is defined as the ongoing systematic collection, recording, 
analysis, interpretation and dissemination of data reflecting the current health status of a 
community or population. It is essential to planning, implementation and evaluation of 
public health practice and is closely integrated with the timely dissemination of these data 
to those who need to know. The definition emphasizes the use of data for public health 
action, not simply the collection of information as an end in itself. 
The objectives of HIV surveillance include the provision of timely and reliable information for:  
 advocacy for resources for prevention and care, mobilization of political commitment  
 appropriate resource allocation between affected populations and areas  
 effective targeting of prevention, care and support programmes  
 monitoring and evaluation of the aggregate impact of programmes  
 developing new programmes  
 informing the public  
 tracking the leading edge of the epidemic  
 projecting future care and prevention needs  
 identifying information gaps and guiding research to fill those gaps  
 making health policies to maximize the effectiveness of the above. 
So, HIV surveillance is trying to provide qualified evidences for decision makers to better 
response to HIV epidemic. In order to reach the above objectives, different elements of HIV 
surveillance has been developed and implemented in different settings. In this chapter we 
review these elements. Before addressing the different elements of HIV surveillance, we 
should have a view of HIV infection and its natural phases of infection.   
2. The natural history of HIV disease and disease stages 
HIV infection results in a chronic condition which is started from primary HIV infection with 
unspecified signs/symptoms (such as fever, muscle aches and swollen glands). Then most 
affected persons have mild or no symptoms for several years. Gradually, as their immune 
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system weakens, they will experiences HIV-related clinical symptoms and illnesses. Without 
specific treatment, the HIV infected person will experience all clinical stages ended with the 
end-stage disease called AIDS (Figure 1).   
 
 
Fig. 1. Key HIV stages which could be reported in HIV case reporting surveillance  
HIV transmitted from an infected person to another mainly through: 
- Unsafe sexual contact 
- Unsafe drug injection   
- Delivery of Breast feeding of a child by the affected mother  
- Unsafe blood transfusion 
As it’s obvious, there drivers of the HIV epidemics in a community are risk behaviors. To 
control the spread of the HIV epidemic, we need to collect information not only on the 
number of affected people and their previous risky behaviors, but also gather strategic 
information on the behaviors of the subpopulations especially who are most at risk for 
acquiring the HIV infection naming female sex workers, injecting drug users, men who have 
sex with men.  Second generation surveillance for HIV/AIDS has been proposed by WHO 
and UNAIDS to provide such information to response to HIV/AIDS epidemic efficiently. 
Second generation surveillance for HIV/AIDS is the regular, systematic collection, analysis 
and interpretation of information for use in tracking and describing changes in the HIV/AIDS 
epidemic over time. Second generation surveillance for HIV/AIDS also gathers information on 
risk behaviors, using them to warn of or explain changes in levels of infection. As such, second 
generation surveillance includes, in addition to HIV surveillance and AIDS case reporting, STI 
surveillance to monitor the spread of STI in populations at risk of HIV and behavioral 
surveillance to monitor trends in risk behaviors over time. These different components achieve 
greater or lesser significance depending of the surveillance needs of a country, determined by 
the level of the epidemic it is facing: low level, concentrated or generalized. 
The core elements of HIV/AIDS Surveillance included  
- HIV/AID Case Reporting 
It’s comparable as disease routine reporting system. Persons diagnosed HIV infection 
(clinical stages 1-4) and/or advanced HIV disease (clinical stages 3 and 4) registered 
and reported systematically through the health system.  
- HIV sentinel sero-prevalence Surveys 
In some health centers, blood is collected routinely for other proposes such as routine 
antenatal cares for pregnant women.  A portion of this blood can be used for HIV testing.   
- Behavioral Sero-Surveys (or Bio-Behavioral Surveys)  
Surveys of HIV-related behavior that involve asking a sample of people about their risk 
behaviors, such as their sexual and drug-injecting behavior. In addition to behavioral 






transmitted diseases. In some settings test for tuberculosis is also integrated. Data on 
behavioral and serological exams are linked and analysis jointly to provide more 
comprehensive information on the HIV epidemics and its determinants.  These Bio-
Behavioral surveys could be divided into two categories: (1) facility based surveys (2) 
community bases surveys. The main differences between these two methods are 
coming from the sampling schemes that applied for recruiting the subjects into the 
survey and the definition of the target population.   
We elaborate different components of HIV surveillance by the course of HIV infection in 
Figure 2. Surveillance for HIV infection could be done at four key points: Before, at, after the 
time of HIV infection and death:   
- Surveillance components at the phase before acquiring HIV infection (Behavioural and 
STI): 
It includes Behavioural and STI surveillance activities. Surveys for estimating the 
prevalence of risky behaviours and inadequate knowledge on ways to prevent HIV 
transmission are measures among the general population or high-risk subpopulation 
(i.e FSWs, IDUs and MSM depend on the context). Sexual Transmitted Infections (STIs) 
surveillance is also helping the country to track the high-risk populations who are 
susceptible to get the HIV infection through sexual routes. STIs treatment and care will 
reduce this susceptibility.   
- Surveillance components at the time of acquiring HIV infection (Incidence): 
It’s addressing the surveillance activities which could provide an estimated of HIV 
incidence. HIV incidence is very hard to be estimated and new methods are proposed 
and implemented. However, many countries did not apply these methods as they are 
expensive and also laboratories do not have the capacities to do these new tests. As a 
strategic alternative, it’s recommended to include early infant diagnosis surveillance for 
having a proxy for incidence measures.   
- Surveillance components after acquiring the HIV infection (Morbidity): 
These include a verity of surveillance activities such as HIV case reporting, Advanced 
HIV case reporting, prevalence studies among the general population or high-risk 
groups, sentinel HIV surveillance among specific groups such as pregnant women at 
the antenatal clinics. These activities will provide information on the direction of the 
HIV epidemic in the population and the burden of disease. HIV drug resistance studies 
also included as the advance component of this phase 
- Surveillance components of dead AIDS cases (Mortality): 
This part includes vital registry of all cases died due to AIDS. 
The rest of the chapter focuses on HIV case reporting surveillance. If you are interested on 
the other components such as Sentinel HIV Surveillance and Bio-Behavioral Surveys, more 
could be found in Guidelines for conducting HIV sentinel serosurveys among pregnant 
women and other groups (2003) and Guidelines for repeated behavioral surveys in 
populations at risk of HIV; Durham, North Carolina, Family Health International (2000). 
3. HIV case reporting  
As one part of the HIV surveillance system, HIV in all clinical stages (including advanced 
HIV cases and AIDS) is an ongoing reporting system in many countries including the low- 
and middle-income countries. Since 2006, World Health Organization (WHO) has 








Fig. 2. Key HIV Surveillance Component by phases of HIV infection [Advances and future 
directions in HIV surveillance Diaz et al. Curr Opin HIV AIDS 4:253-259] 
These identified cases are reported confidentially either by names or by anonymous codes.  
HIV case reporting refers to the methods used to capture individual-level information about 
persons with HIV infection. Each person with HIV infection is reported using a single case 
report form which contains information pertaining only to that person. This type of 
reporting occurs at the level of the health facility and is forwarded to the local level as 
individual case reports. The local-level surveillance officers combine the data and forward 
them on to the national surveillance programme where they will be computerized. 
WHO refers to reporting all stages of HIV as “HIV infection reporting (all clinical stages)” 
(Table1) and to reporting of advanced HIV (clinical stages 3 and 4 only) as “advanced HIV 




months or older 
HIV infection is diagnosed based on: 
Positive HIV antibody testing (rapid or laboratory-based enzyme 
immunoassay). This is confirmed by a second HIV antibody test (rapid 
or laboratory-based enzyme immunoassay) relying on different 
antigens or of different operating characteristics; 
and/or; 
Positive biological test for HIV or its components (HIV-RNA or HIV-
DNA or ultrasensitive HIV p24 antigen) confirmed by a second 
virological test obtained from a separate determination. 
Children younger 
than 18 months: 
HIV infection is diagnosed based on: 
positive virological test for HIV or its components (HIV-RNA or HIV-
DNA or ultrasensitive HIV p24 antigen) confirmed by a second 
virological test obtained from a separate determination taken more 
than four weeks after birth. Positive HIV antibody testing is not 
recommended for definitive or confirmatory diagnosis of HIV infection 
in children until 18 months of age. 






Cases diagnosed with advanced HIV infection (including AIDS) not previously reported 
should be reported according to a standard case definition. Advanced HIV infection (Table 
2) is diagnosed based on clinical and/or immunological (CD4) criteria (Table 3) among 
people with confirmed HIV infection. AIDS case reporting for surveillance is no longer 
required if HIV infection or advanced HIV infection is reported. 
Advanced HIV infection is diagnosed based on clinical and/or immunological (CD4) criteria 
among people with confirmed HIV infection: 
 
Criteria for diagnosis of advanced HIV (including AIDS) for reporting 
Clinical criteria for diagnosis of advanced HIV in adults and children with confirmed 
HIV infection: 




Immunological criteria for diagnosing advanced HIV in adults and children five years or 
older with confirmed HIV infection: 
 CD4 count less than 350 per mm3 of blood in an HIV-infected adult or child. 
 
and/or; 
Immunological criteria for diagnosing advanced HIV in a child younger than five years 
of age with confirmed HIV infection: 
 %CD4+ <30 among those younger than 12 months; 
 %CD4+ <25 among those aged 12–35 months; 
 %CD4+ <20 among those aged 36–59 months. 










36 –59 months 
(%CD4+) 
>5 years (absolute 
number per mm3 
or %CD4+) 
None or not significant >35 >30 >25 > 500 
Mild 30–35 25–30 20–25 350−499 
Advanced 25–29 20–24 15−19 200−349 
Severe <25 <20 <15 <200 or <15% 
Table 3. WHO immunological classification for established HIV infection 
                                                 
1World Health Organization, WHO case definitions of HIV for surveillance and revised clinical staging 
and immunological classification of HIV-related disease in adults and children. 2007 
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4. Events which could be reported in HIV case reporting  
HIV case reporting, if developed / implemented properly, can provide the health 
authorities necessary information which are needed for better understanding of the  HIV 
epidemic and monitoring the success of the programmes. The reported cases at any stages of 
the disease could be used for producing the following indicators:  
 HIV incidence (the number or percentage of new HIV infections) 
 HIV prevalence (the number or percentage of all persons living with HIV, regardless of 
how long they have been infected or whether or not they are aware of their infection) 
 The incidence of advanced HIV infection  
 The prevalence of advanced HIV infection  
 Deaths from advanced HIV infection. 
5. Elements of a case report form 
A comprehensive case report form should include: 
 Administrative information 
 Name and address of facility where the report is submitted from (reporting source) 
 Date form completed 
 Report status (new or update) 
 Demographic information 
 Patient identifier (name or code) 
 Date of birth 
 Sex 
 Current status (alive, dead, unknown) 
 Country of residence  
 Information on the patient’s HIV-related risk behaviour 
 Sex with male  
 Sex with female 
 Injected non-prescription drugs 
 Perinatal/MTCT  
 Blood transmission-related variables 
 Occupational exposure 
 Diagnosis information  
 Date of HIV diagnosis  
 Facility of diagnosis 
 HIV clinical stage  
 Date of first clinical stage 
 Clinical stage 
 Date of first clinical stage 3 diagnosis 
 Date of first clinical stage 4 diagnosis 
 Immunologic status 
 Date of first CD4 test 
 Result of first CD4 test (count and/or percentage) 
 Date of first CD4 count <350 cells/mm3 






 Care and treatment 
 Use of ART 
 Date first used ART 
 Use of prophylaxis against Pneumocystis jirovecii pneumonia 
 Vital status 
 Date of death 
 Cause of death.  
Countries should carefully consider which elements to include in the case report form. It 
should include only information that is readily available to the person completing the form 
and that can be collected from most of the reporting facilities. It should not be a burden to 
people who complete it. 
6. Flow of data 
We elaborate this section by presenting an example of health system in a country which 
medical universities providing health for the people in all areas of the country. Here, the 
flow of data is divided into four levels (Figure 3). 
 
 
Fig. 3. Flow of data in a country designed in four levels 
Level 1 - Health Facilities: all urban and rural health centers, clinics, hospitals, private 
offices at the time of diagnosis an HIV case in all clinical stages should report the case. 
 Activities: the responsible staff fill Form 1 for every one who meets the case definition 
and report the case to level 2  
Level 2 - District health centers: these are district health centers which are responsible for 
providing health to district inhabitants.  
 Activities: every month, the responsible staff will compile the received data and then 
fill an aggregated data reporting form and submit it to the Center for Disease Control of 
the University. By doing sort of data analysis, feedbacks developed and send to the 
health facilities working in the district.   
Level 3 – Center for Disease Control at the University:  
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 Activities: every month, the responsible staff will compile the received data and then 
fill out an aggregated data reporting form to be sent to the Center for Disease Control of 
the Ministry (National Surveillance Unit). By doing sort of data analysis, feedbacks 
developed and send to the district health centers.   
Level 4 –Center for District Control at the Ministry (National Surveillance Unit):  
 Activities: every three months, the responsible staff will compile the received data, 
make a comprehensive analysis on the received data, and draft the quarterly national 
surveillance report and distribute it to all the stakeholders to be used.  
7. Analysis and feedbacks on cases reporting surveillance 
Most of the time, analysis of surveillance data is mainly done only by descriptive analysis to 
estimate the level of indicators such as the number of affected people by sex, percentage of 
those cases reported sexual contact as the most probable route of transmission. These 
estimates should be interpreted according to time to explore the trends and direction of the 
epidemic. As an example, here we elaborate the analysis and feedback steps of a national 
HIV case reporting surveillance (in line with the previous section) 
Level 2 feedbacks: every three months, HIV surveillance report including the last status of 
HIV in the district and the trend analysis of the reported data should be sent to all  health 
facilities (even if they did not reported any case of HIV during the period). Such report 
should have at least the following information: 
1. Three months trend 
2. Three months trend in compare to the previous three-month period 
3. Total number of reported cases by age and sex groups including the main routes of 
transmission.  
Level 3 feedbacks: every three months, HIV surveillance report including the last status of 
HIV in the province and the trend analysis of the reported data should be sent to all  district 
health centers (even if they did not reported any case of HIV during the period).  
Such reports should have at least the following information: 
1. Three months trend 
2. Three months trend in compare to the previous three-month period 
3. Total number of reported cases by age and sex groups including the main routes of 
transmission.  
Level 4 feedbacks: every three months, HIV surveillance report including the last status of 
HIV in the province and the trend analysis of the reported data should be sent to all  district 
health centers (even if they did not reported any case of HIV during the period).  
Such reports should have at least the following information: 
1. Three months trend 
2. Three months trend in compare to the previous three-month period 
3. Total number of reported cases by age and sex groups including the main routes of 
transmission.  
If an increase of 10% has been observed in a university for a period of two sequential 
months, the feedback should be send to that university and the neighborhood universities 







8. Core indicators according to the phases of the infection 
-  Surveillance components at the phase before acquiring HIV infection (Behavioural and 
STI): 
As mentioned before, here the focus is on measuring the risky behaviors which make 
people susceptible for acquiring the infection. So, samples of people requited in a 
behavioral survey and complete a questionnaire including sections for sexual behaviors, 
drug injection and knowledge for HIV prevention, and history of HIV testing and 
counseling. This data is applied for produce behavioral indicators which used to 
compare populations, geographic areas and programme impact over time. Examples of 
these interfamily wide-use indicators are:  
 percentage of women and men aged 15–49 who received HIV testing in the previous 12 
months and who know their results 
 percentage of most-at-risk populations reached by HIV prevention programmes 
 percentage of young women and men who have had sexual intercourse before the age 
of 15 
 percentage of female and male sex workers reporting use of a condom with their most 
recent client 
 percentage of injection drug users who reported using sterile injection equipment the 
most recent time they injected 
- Surveillance components after acquiring the HIV infection (Morbidity): 
 Percentage of young women and men aged 15 to 24 who are HIV-infected 
 Percentage of most-at-risk populations who are HIV-infected. 
Although different indicators have been proposed by many international bodies including 
UNAIDS and WHO, countries should decide from which they will benefit from and is much 
related to the context and their level of HIV epidemics. They should define the target groups 
of HIV surveillance and adopt the indicators accordingly.   
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